VFC
50
-2
ADSK
68
-2
XOM
40
-7
AMG
57
2
ADBE
61
11
COP
47
2
AES
41
-2
INTC
40
-4
SHW
68
-5
KSS
26
-15
KLAC
53
-3
SRE
45
-9
CTSH
60
3
DUK
64
7
SWKS
51
-2
OXY
37
-3
UHS
62
6
BRK.B
45
2
PPG
61
-4
XYL
49
-7
VFC
50
-2
ADSK
68
-2
XOM
40
-7
AMG
57
2
ADBE
61
11
COP
47
2
AES
41
-2
INTC
40
-4
SHW
68
-5
KSS
26
-15
KLAC
53
-3
SRE
45
-9
CTSH
60
3
DUK
64
7
SWKS
51
-2
OXY
37
-3
UHS
62
6
BRK.B
45
2
PPG
61
-4
XYL
49
-7
Financhill
Back

Akero Therapeutics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67

AKRO
Akero Therapeutics

Last Price:
31.48
Seasonality Move:
5.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 24% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $31.16. The Score for AKRO is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 24% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Buy
67
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • The current trend is moderately bullish and AKRO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
37.00
52-Week Low:
15.32

Prediction Charts

Market Cap:
2.17B
Price in USD:
31.16
Volume:
396.81K
Beta:
-0.28

Technical Analysis

SMA50:
30.06
SMA100:
28.02
SMA200:
25.47
52-Wk Change:
90.7%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 31.16 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-7 35.26 34.87 35.88 34.56
Nov-8 34.73 34.43 34.73 33.35
Nov-11 34.77 33.04 35.11 32.70
Nov-12 32.80 32.38 34.54 31.96
Nov-13 32.58 30.97 32.79 30.95
Nov-14 30.83 29.76 31.43 29.53
Nov-15 29.97 28.09 30.01 27.05
Nov-18 28.72 29.56 29.85 28.44
Nov-19 29.34 31.03 31.10 29.10
Nov-20 30.72 30.64 31.60 29.88
Nov-21 30.88 31.20 31.27 29.97
Nov-22 31.55 32.73 32.95 31.05
Nov-25 32.84 31.77 33.30 31.73
Nov-26 31.70 31.16 32.03 30.69

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.